Madrigal Pharmaceuticals, Inc. earnings per share and revenue

MDGL earnings per share for the last quarter are -4.92 USD whereas the estimation was -6.75 USD which accounts for 27.09% surprise. Company revenue for the same period amounts to 62.20 M USD despite the estimated figure of 34.60 M USD. Estimated earnings per share for the next quarter are -4.51 USD, and revenue is expected to reach 87.37 M USD. Also watch annual changes over time to get a bigger picture of MDGL earnings per share and revenue dynamics.